Mkael Symmonds
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mkael Symmonds has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Sarosh R. Irani
Department of Neurology Mayo Clinic Jacksonville Florida USA
3 shared publications - Arjune Sen
University of Oxford
2 shared publications - Christine Lo
Department of Clinical Neurology Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
2 shared publications - Raymond J. Dolan
Max Planck UCL Centre for Computational Psychiatry and Ageing Research, University College London
2 shared publications Ursula G. Schulz
From John Radcliffe Hospital, Oxford University, Oxford, UK
2 shared publications- Wilhelm Küker
University of Münster Faculty of Medicine, Germany
2 shared publications
Latest Publications
- Open Access
- 27 June 2026
- Published by Wiley in Epileptic Disorders
NMDAR ‐antibody encephalitis: Seizure semiology and EEG findings
Background: N‐methyl‐D‐aspartate receptor antibody encephalitis (NMDAR‐Ab‐E) is an autoantibody‐mediated disorder, characterized by acute development of neuropsychiatric symptoms, seizures, movement disorders, and autonomic instability. Objectives: To describe acute seizure semiology and electroencephalogram (EEG) findings in patients with a first episode of NMDAR‐Ab‐E. Methods: Medical records and EEG results were retrospectively evaluated from 14 adult patients with definite NMDAR‐Ab‐E, recruited between April 2009 and September 2017, and followed up until October 2024. Results: A total of 92.8% (13/14) were women with a mean age of 29.6 years. 85.7% (12/14) patients experienced seizures. Focal and/or generalized seizures were described at presentation or in the first days of the illness in 57% (8/14). EEGs showed diffuse slowing in 13/14 and this coexisted with epileptiform activity in 10/13; fast frequencies in 7/13 (potentially owing to a benzodiazepine effect); and asymmetric focal slowing in 6/13. Six patients had periods of rhythmic slow activity (focal or diffuse), without evolution to electrographic seizures. An extreme delta brush (EDB) pattern was recorded in 2/13 patients, and this was associated with non‐convulsive status epilepticus in one of these individuals. Significance: Most patients in this case series of NMDAR‐Ab‐E were young adult females with early focal and/or generalized seizures. Diffuse slowing in theta/delta range was the most common EEG finding, with or without epileptiform discharges, focal slowing, superimposed fast activities, and focal or diffuse rhythmic slowing. An EDB pattern was rare. Even with non‐specific findings, EEG seems to be a sensitive tool to aid diagnosis and decision‐making in NMDAR‐Ab‐E.
- 27 June 2026
- Published by Wiley in Epileptic Disorders
Open AccessNMDAR ‐antibody encephalitis: Seizure semiology and EEG findings
Background: N‐methyl‐D‐aspartate receptor antibody encephalitis (NMDAR‐Ab‐E) is an autoantibody‐mediated disorder, characterized by acute development of neuropsychiatric symptoms, seizures, movement disorders, and autonomic instability. Objectives: To describe acute seizure semiology and electroencephalogram (EEG) findings in patients with a first episode of NMDAR‐Ab‐E. Methods: Medical records and EEG results were retrospectively evaluated from 14 adult patients with definite NMDAR‐Ab‐E, recruited between April 2009 and September 2017, and followed up until October 2024. Results: A total of 92.8% (13/14) were women with a mean age of 29.6 years. 85.7% (12/14) patients experienced seizures. Focal and/or generalized seizures were described at presentation or in the first days of the illness in 57% (8/14). EEGs showed diffuse slowing in 13/14 and this coexisted with epileptiform activity in 10/13; fast frequencies in 7/13 (potentially owing to a benzodiazepine effect); and asymmetric focal slowing in 6/13. Six patients had periods of rhythmic slow activity (focal or diffuse), without evolution to electrographic seizures. An extreme delta brush (EDB) pattern was recorded in 2/13 patients, and this was associated with non‐convulsive status epilepticus in one of these individuals. Significance: Most patients in this case series of NMDAR‐Ab‐E were young adult females with early focal and/or generalized seizures. Diffuse slowing in theta/delta range was the most common EEG finding, with or without epileptiform discharges, focal slowing, superimposed fast activities, and focal or diffuse rhythmic slowing. An EDB pattern was rare. Even with non‐specific findings, EEG seems to be a sensitive tool to aid diagnosis and decision‐making in NMDAR‐Ab‐E.
- Open Access
- 20 April 2026
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (7)
Towards automated joint detection in sleep studies: bridging clinical insight and artificial intelligence
Study objectives: To develop and evaluate artificial intelligence methods for detecting upper-body joint positions from video recordings of individuals during sleep, providing a foundation for future automated, video-based analysis of sleep movements that extends beyond conventional sensor-based methods. Methods: We developed HypnoPose and tested five different model configurations. We pretrained each variant on a public body pose dataset and evaluated on a sleep pose dataset comprising 4419 annotated frames from 198 video segments depicting movement across 74 participants (10 RBD, 4 PD, 9 healthy controls, 51 referred for vPSG screening) recorded in clinical and home settings. We manually annotated each frame with 13 body joints, visibility flags, and head orientation. We evaluated model performance against state-of-the-art pose estimators using precision (mAP) and recall (mAR) metrics based on Object Keypoint Similarity (OKS). Results: HypnoPose achieved the highest performance (mAP: 0.088, AP@0.5: 0.326) in the sleep domain, doubling baseline HigherHRNet results (mAP: 0.041, AP@0.5: 0.165) and outperforming gold-standard architectures. It showed 40%–120% relative mAP improvement for occluded joints, enhancing detection of the head, shoulders, and elbows. Home recordings showed higher precision than clinic data (mAP 0.14 vs 0.07). Within clinic recordings, NREM stages outperform Wake (mAP 0.11–0.13 vs 0.06). Conclusions: We present a proof-of-concept for detecting upper-body joint positions from sleep images, even when blankets occlude the person. Our method improves relative precision by 115% compared to standard models. While absolute performance remains modest, this work establishes a first step toward clinically applicable, video-based pose estimation during sleep. Future work should integrate contextual priors and expand annotated sleep datasets. Statement of Significance Video polysomnography (vPSG) is the gold standard for assessing sleep-related disorders. It is resource-intensive, requires specialist expertise for setup and interpretation, and may not capture typical sleep due to the presence of multiple sensors and the laboratory environment. In some populations, such as individuals with REM sleep behavior disorder (RBD), vPSG can be challenging, and clinically relevant behaviors may not occur during a single recording night. At-home recordings provide greater environmental validity but are often constrained by nonstandard camera positioning and suboptimal lighting. This study introduces a benchmark for automated, frame-wise upper-body pose estimation, to identify anatomical joint positions during sleep. While tools for detecting periodic limb movements and REM sleep without atonia already exist, there remains a critical need for objective, scalable methods to quantify complex movements seen in disorders such as RBD, NREM parasomnias, and sleep-related epilepsies. This work lays the foundation for future automated, noncontact movement analysis that complements existing vPSG workflows, reduces manual review time, and supports accessible monitoring of sleep behavior in both clinical and home environments.
- 20 April 2026
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (7)
Open AccessTowards automated joint detection in sleep studies: bridging clinical insight and artificial intelligence
Study objectives: To develop and evaluate artificial intelligence methods for detecting upper-body joint positions from video recordings of individuals during sleep, providing a foundation for future automated, video-based analysis of sleep movements that extends beyond conventional sensor-based methods. Methods: We developed HypnoPose and tested five different model configurations. We pretrained each variant on a public body pose dataset and evaluated on a sleep pose dataset comprising 4419 annotated frames from 198 video segments depicting movement across 74 participants (10 RBD, 4 PD, 9 healthy controls, 51 referred for vPSG screening) recorded in clinical and home settings. We manually annotated each frame with 13 body joints, visibility flags, and head orientation. We evaluated model performance against state-of-the-art pose estimators using precision (mAP) and recall (mAR) metrics based on Object Keypoint Similarity (OKS). Results: HypnoPose achieved the highest performance (mAP: 0.088, AP@0.5: 0.326) in the sleep domain, doubling baseline HigherHRNet results (mAP: 0.041, AP@0.5: 0.165) and outperforming gold-standard architectures. It showed 40%–120% relative mAP improvement for occluded joints, enhancing detection of the head, shoulders, and elbows. Home recordings showed higher precision than clinic data (mAP 0.14 vs 0.07). Within clinic recordings, NREM stages outperform Wake (mAP 0.11–0.13 vs 0.06). Conclusions: We present a proof-of-concept for detecting upper-body joint positions from sleep images, even when blankets occlude the person. Our method improves relative precision by 115% compared to standard models. While absolute performance remains modest, this work establishes a first step toward clinically applicable, video-based pose estimation during sleep. Future work should integrate contextual priors and expand annotated sleep datasets. Statement of Significance Video polysomnography (vPSG) is the gold standard for assessing sleep-related disorders. It is resource-intensive, requires specialist expertise for setup and interpretation, and may not capture typical sleep due to the presence of multiple sensors and the laboratory environment. In some populations, such as individuals with REM sleep behavior disorder (RBD), vPSG can be challenging, and clinically relevant behaviors may not occur during a single recording night. At-home recordings provide greater environmental validity but are often constrained by nonstandard camera positioning and suboptimal lighting. This study introduces a benchmark for automated, frame-wise upper-body pose estimation, to identify anatomical joint positions during sleep. While tools for detecting periodic limb movements and REM sleep without atonia already exist, there remains a critical need for objective, scalable methods to quantify complex movements seen in disorders such as RBD, NREM parasomnias, and sleep-related epilepsies. This work lays the foundation for future automated, noncontact movement analysis that complements existing vPSG workflows, reduces manual review time, and supports accessible monitoring of sleep behavior in both clinical and home environments.
- Open Access
- 5 July 2022
- Published by Springer Nature in Journal of Neurology
- Vol. 269 (10) , 5302-5311
The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
Background: A variety of psychiatric syndromes are associated with NMDAR autoantibodies; however, their clinical relevance when only present in the serum is unclear. We explored whether patients with CSF NMDAR autoantibodies could be distinguished from patients with serum-only NMDAR autoantibodies. Methods: The electronic databases MEDLINE, EMBASE, PubMed, and PsycINFO were searched. Articles reporting adult patients with isolated psychiatric features and positive for NMDAR autoantibodies with relevant investigations were included. Patient level meta-analysis compared patients positive for CSF NMDAR autoantibodies with patients positive for serum NMDAR autoantibodies, but negative for CSF NMDAR autoantibodies. Dichotomous data were analysed using crude odds ratios (OR), whilst continuous data were analysed using Mann–Whitney Test (U). The protocol was prospectively registered (CRD42018082210). Results: Of 4413 publications, 42 were included, reporting 79 patients. Median age was 34 years (IQR 19 years); 56% (45/79) were female and 24% (16/68) had a tumour. In total, 41 patients were positive for CSF autoantibodies and 20 were positive for serum-only autoantibodies. Patients with CSF autoantibodies were significantly more likely to be female (p < 0.001) and have a rapid (< 3 month) onset of symptoms (p = 0.02) than patients with serum-only autoantibodies. They were also more likely to present with psychosis (p < 0.001), exhibit EEG (p = 0.006), MRI (p = 0.002), and CSF (p = 0.001) abnormalities, but less likely to present with insomnia (p = 0.04). Conclusions: Patients with an isolated psychiatric syndrome with CSF NMDAR autoantibodies can potentially be distinguished from those with serum-only NMDAR autoantibodies based on clinicodemographic and investigation findings.
- 5 July 2022
- Published by Springer Nature in Journal of Neurology
- Vol. 269 (10) , 5302-5311
Open AccessThe clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
Background: A variety of psychiatric syndromes are associated with NMDAR autoantibodies; however, their clinical relevance when only present in the serum is unclear. We explored whether patients with CSF NMDAR autoantibodies could be distinguished from patients with serum-only NMDAR autoantibodies. Methods: The electronic databases MEDLINE, EMBASE, PubMed, and PsycINFO were searched. Articles reporting adult patients with isolated psychiatric features and positive for NMDAR autoantibodies with relevant investigations were included. Patient level meta-analysis compared patients positive for CSF NMDAR autoantibodies with patients positive for serum NMDAR autoantibodies, but negative for CSF NMDAR autoantibodies. Dichotomous data were analysed using crude odds ratios (OR), whilst continuous data were analysed using Mann–Whitney Test (U). The protocol was prospectively registered (CRD42018082210). Results: Of 4413 publications, 42 were included, reporting 79 patients. Median age was 34 years (IQR 19 years); 56% (45/79) were female and 24% (16/68) had a tumour. In total, 41 patients were positive for CSF autoantibodies and 20 were positive for serum-only autoantibodies. Patients with CSF autoantibodies were significantly more likely to be female (p < 0.001) and have a rapid (< 3 month) onset of symptoms (p = 0.02) than patients with serum-only autoantibodies. They were also more likely to present with psychosis (p < 0.001), exhibit EEG (p = 0.006), MRI (p = 0.002), and CSF (p = 0.001) abnormalities, but less likely to present with insomnia (p = 0.04). Conclusions: Patients with an isolated psychiatric syndrome with CSF NMDAR autoantibodies can potentially be distinguished from those with serum-only NMDAR autoantibodies based on clinicodemographic and investigation findings.
- 1 March 2020
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 76, 153-155
Very late-onset mitochondrial cytopathy featuring epilepsia partialis continua and bilateral deafness: A case report
- 1 March 2020
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 76, 153-155
Very late-onset mitochondrial cytopathy featuring epilepsia partialis continua and bilateral deafness: A case report
- Open Access
Screening for REM Sleep Behaviour Disorder with Minimal Sensors
Rapid-Eye-Movement (REM) sleep behaviour disorder (RBD) is an early predictor of Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. This study investigates a minimal set of sensors to achieve effective screening for RBD in the population, integrating automated sleep staging (three state) followed by RBD detection without the need for cumbersome electroencephalogram (EEG) sensors. Polysomnography signals from 50 participants with RBD and 50 age-matched healthy controls were used to evaluate this study. Three stage sleep classification was achieved using a Random Forest (RF) classifier and features derived from a combination of cost-effective and easy to use sensors, namely electrocardiogram (ECG), electrooculogram (EOG), and electromyogram (EMG) channels. Subsequently, RBD detection was achieved using established and new metrics derived from ECG and EMG metrics. The EOG and EMG combination provided the best minimalist fully automated performance, achieving $0.57\pm0.19$ kappa (3 stage) for sleep staging and an RBD detection accuracy of $0.90\pm0.11$, (sensitivity, and specificity $0.88\pm0.13$, and $0.92\pm0.098$). A single ECG sensor allowed three state sleep staging with $0.28\pm0.06$ kappa and RBD detection accuracy of $0.62\pm0.10$. This study demonstrated the feasibility of using signals from a single EOG and EMG sensor to detect RBD using fully-automated techniques. This study proposes a cost-effective, practical, and simple RBD identification support tool using only two sensors (EMG and EOG), ideal for screening purposes.Open AccessScreening for REM Sleep Behaviour Disorder with Minimal Sensors
Rapid-Eye-Movement (REM) sleep behaviour disorder (RBD) is an early predictor of Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. This study investigates a minimal set of sensors to achieve effective screening for RBD in the population, integrating automated sleep staging (three state) followed by RBD detection without the need for cumbersome electroencephalogram (EEG) sensors. Polysomnography signals from 50 participants with RBD and 50 age-matched healthy controls were used to evaluate this study. Three stage sleep classification was achieved using a Random Forest (RF) classifier and features derived from a combination of cost-effective and easy to use sensors, namely electrocardiogram (ECG), electrooculogram (EOG), and electromyogram (EMG) channels. Subsequently, RBD detection was achieved using established and new metrics derived from ECG and EMG metrics. The EOG and EMG combination provided the best minimalist fully automated performance, achieving $0.57\pm0.19$ kappa (3 stage) for sleep staging and an RBD detection accuracy of $0.90\pm0.11$, (sensitivity, and specificity $0.88\pm0.13$, and $0.92\pm0.098$). A single ECG sensor allowed three state sleep staging with $0.28\pm0.06$ kappa and RBD detection accuracy of $0.62\pm0.10$. This study demonstrated the feasibility of using signals from a single EOG and EMG sensor to detect RBD using fully-automated techniques. This study proposes a cost-effective, practical, and simple RBD identification support tool using only two sensors (EMG and EOG), ideal for screening purposes. - Open Access
- 1 August 2017
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 50, 14-17
LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures
- 1 August 2017
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 50, 14-17
Open AccessLGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures
- 17 March 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (11) , 1177-1179
Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is an inflammatory brainstem syndrome of uncertain etiology, with distinct radiologic features.1 Autoimmunity has been postulated, although specific CNS antibodies have not been reported. Our patient initially presented with classical clinicoradiologic features of CLIPPERS. Five months later, she developed a longitudinally extensive spinal cord inflammatory lesion affecting mainly the conus, and had antibodies to myelin-oligodendrocyte glycoprotein (MOG). Although neuromyelitis optica spectrum disorders (NMOSD) with brainstem involvement may feature in the broad differential diagnosis of CLIPPERS, this is the first report describing an overlap with the anti-MOG phenotype of NMOSD, and highlights that CLIPPERS may not be a distinct nosologic entity.
- 17 March 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (11) , 1177-1179
Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is an inflammatory brainstem syndrome of uncertain etiology, with distinct radiologic features.1 Autoimmunity has been postulated, although specific CNS antibodies have not been reported. Our patient initially presented with classical clinicoradiologic features of CLIPPERS. Five months later, she developed a longitudinally extensive spinal cord inflammatory lesion affecting mainly the conus, and had antibodies to myelin-oligodendrocyte glycoprotein (MOG). Although neuromyelitis optica spectrum disorders (NMOSD) with brainstem involvement may feature in the broad differential diagnosis of CLIPPERS, this is the first report describing an overlap with the anti-MOG phenotype of NMOSD, and highlights that CLIPPERS may not be a distinct nosologic entity.
- Open Access
- 21 September 2014
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 25 (10) , 3629-3639
Dopamine, Salience, and Response Set Shifting in Prefrontal Cortex
Dopamine is implicated in multiple functions, including motor execution, action learning for hedonically salient outcomes, maintenance, and switching of behavioral response set. Here, we used a novel within-subject psychopharmacological and combined functional neuroimaging paradigm, investigating the interaction between hedonic salience, dopamine, and response set shifting, distinct from effects on action learning or motor execution. We asked whether behavioral performance in response set shifting depends on the hedonic salience of reversal cues, by presenting these as null (neutral) or salient (monetary loss) outcomes. We observed marked effects of reversal cue salience on set-switching, with more efficient reversals following salient loss outcomes. l-Dopa degraded this discrimination, leading to inappropriate perseveration. Generic activation in thalamus, insula, and striatum preceded response set switches, with an opposite pattern in ventromedial prefrontal cortex (vmPFC). However, the behavioral effect of hedonic salience was reflected in differential vmPFC deactivation following salient relative to null reversal cues. l-Dopa reversed this pattern in vmPFC, suggesting that its behavioral effects are due to disruption of the stability and switching of firing patterns in prefrontal cortex. Our findings provide a potential neurobiological explanation for paradoxical phenomena, including maintenance of behavioral set despite negative outcomes, seen in impulse control disorders in Parkinson's disease.
- 21 September 2014
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 25 (10) , 3629-3639
Open AccessDopamine, Salience, and Response Set Shifting in Prefrontal Cortex
Dopamine is implicated in multiple functions, including motor execution, action learning for hedonically salient outcomes, maintenance, and switching of behavioral response set. Here, we used a novel within-subject psychopharmacological and combined functional neuroimaging paradigm, investigating the interaction between hedonic salience, dopamine, and response set shifting, distinct from effects on action learning or motor execution. We asked whether behavioral performance in response set shifting depends on the hedonic salience of reversal cues, by presenting these as null (neutral) or salient (monetary loss) outcomes. We observed marked effects of reversal cue salience on set-switching, with more efficient reversals following salient loss outcomes. l-Dopa degraded this discrimination, leading to inappropriate perseveration. Generic activation in thalamus, insula, and striatum preceded response set switches, with an opposite pattern in ventromedial prefrontal cortex (vmPFC). However, the behavioral effect of hedonic salience was reflected in differential vmPFC deactivation following salient relative to null reversal cues. l-Dopa reversed this pattern in vmPFC, suggesting that its behavioral effects are due to disruption of the stability and switching of firing patterns in prefrontal cortex. Our findings provide a potential neurobiological explanation for paradoxical phenomena, including maintenance of behavioral set despite negative outcomes, seen in impulse control disorders in Parkinson's disease.
- 1 July 2014
- Published by Wolters Kluwer Health in Neurology
- Vol. 83 (1) , e6-e10
Clinical Reasoning: Progressive visuospatial problems in a 71-year-old man
A 71-year-old right-handed man presented with a 3-month history of progressive cognitive impairment. Six weeks before presentation, he became unable to use his mobile phone, with difficulties pressing the digits in the correct order. He had developed problems reading, describing a jumbled-up appearance of words on the page. He omitted single letters when writing, and had difficulty in using cutlery and accurately judging portion sizes. He had ceased driving due to navigational problems and because of repeatedly hitting the curb. In the last 4 weeks, he had developed difficulty dressing. Notably, he had good insight, being able to give a detailed description of symptoms.
- 1 July 2014
- Published by Wolters Kluwer Health in Neurology
- Vol. 83 (1) , e6-e10
Clinical Reasoning: Progressive visuospatial problems in a 71-year-old man
A 71-year-old right-handed man presented with a 3-month history of progressive cognitive impairment. Six weeks before presentation, he became unable to use his mobile phone, with difficulties pressing the digits in the correct order. He had developed problems reading, describing a jumbled-up appearance of words on the page. He omitted single letters when writing, and had difficulty in using cutlery and accurately judging portion sizes. He had ceased driving due to navigational problems and because of repeatedly hitting the curb. In the last 4 weeks, he had developed difficulty dressing. Notably, he had good insight, being able to give a detailed description of symptoms.
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 7, 146
The chronometry of risk processing in the human cortex
The neuroscience of human decision-making has focused on localising brain activity correlating with decision variables and choice, most commonly using functional MRI. Poor temporal resolution means these studies are agnostic in relation to how decisions unfold in time. Consequently, here we address the temporal evolution of neural activity related to encoding of risk using magnetoencephalography (MEG), and show modulations of electromagnetic power in posterior parietal and dorsomedial prefrontal cortex which scale with both variance and skewness in a lottery, detectable within 500ms following stimulus presentation. Electromagnetic responses in somatosensory cortex following this risk encoding predict subsequent choices. Furthermore, within anterior insula we observed early and late effects of subject-specific risk preferences, suggestive of a role in both risk assessment and risk anticipation during choice. The observation that cortical activity tracks specific and independent components of risk from early time-points in a decision making task supports the hypothesis that specialised brain circuitry underpins risk perception.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 7, 146
Open AccessThe chronometry of risk processing in the human cortex
The neuroscience of human decision-making has focused on localising brain activity correlating with decision variables and choice, most commonly using functional MRI. Poor temporal resolution means these studies are agnostic in relation to how decisions unfold in time. Consequently, here we address the temporal evolution of neural activity related to encoding of risk using magnetoencephalography (MEG), and show modulations of electromagnetic power in posterior parietal and dorsomedial prefrontal cortex which scale with both variance and skewness in a lottery, detectable within 500ms following stimulus presentation. Electromagnetic responses in somatosensory cortex following this risk encoding predict subsequent choices. Furthermore, within anterior insula we observed early and late effects of subject-specific risk preferences, suggestive of a role in both risk assessment and risk anticipation during choice. The observation that cortical activity tracks specific and independent components of risk from early time-points in a decision making task supports the hypothesis that specialised brain circuitry underpins risk perception.